Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its target price raised by LADENBURG THALM/SH SH from $10.00 to $12.00 in a research report sent to investors on Monday, FlyOnTheWall reports. CRVS has been the subject of a number of other research reports. Cantor Fitzgerald raised their price objective on shares of Corvus Pharmaceuticals from $2.00 […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) had its price target increased by equities research analysts at LADENBURG THALM/SH SH from $10.00 to $12.00 in a note issued to investors on Monday, FlyOnTheWall reports. LADENBURG THALM/SH SH’s price objective points to a potential upside of 324.03% from the company’s previous close. A number of other […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 780,600 shares, a decrease of 19.8% from the May 31st total of 973,100 shares. Currently, 2.3% of the shares of the company are short […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) fell 1.7% during trading on Tuesday . The company traded as low as $2.23 and last traded at $2.25. 153,512 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,148,757 shares. The stock had previously closed at $2.29. Wall Street Analysts […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Rating) was the target of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 973,100 shares, a growth of 113.6% from the May 15th total of 455,500 shares. Based on an average daily trading volume, of 862,100 shares, […]